All articles by Anne-Charlotte Ackermann
Anne-Charlotte Ackermann
Brukinsa: launch sequence of first Chinese cancer drug to roll out internationally
Two years after it received US FDA approval, BeiGene’s Brukinsa (zanubrutinib) has made steady progress around the world.
2021: a record year for orphan therapies
In this blog, the Poli team looks back at the 2021 pricing and reimbursement trends in the orphan drug space in 7 countries: Europe-5 (France, Germany, Italy, Spain and the UK), Japan and the US.
